Target intelligence / Profile preview

Progenitor cell

Molecular classification
Cellular classification
01

Overview

A **progenitor cell** is a partially differentiated cell that arises from stem cells and has a limited capacity to divide before differentiating into one or more specialized cell types. Progenitor cells are further along the differentiation pathway than stem cells and typically possess restricted potency—usually oligopotent or unipotent. They play essential roles in tissue maintenance, regeneration, and development, being present in many organs such as bone marrow (hematopoietic progenitors), brain (neural progenitors), and muscle (muscle satellite cells)[1][3][5]. Progenitor cells are not a singular molecular entity but represent a functional category within cell biology. In disease, certain progenitor cell populations may serve as cells of origin in cancers, particularly in specific subtypes of breast cancer[2][4]. **Note:** "Progenitor cell" is not a specific molecular target or receptor and should not be used as a primary therapeutic target identifier in databases or structured biomedical resources[1][2][5].

Other names
Precursor cellintermediate precursor cell
02

Mechanism of action

Not applicable for the broad "progenitor cell" class; some drugs may affect proliferation, differentiation, or survival of progenitor cells as part of regenerative or anti-cancer strategies

03

Biological functions

Cell differentiationTissue repairCell proliferationBlood and immune cell development (hematopoiesis)Embryonic developmentCellular maintenance
04

Disease associations

Cancer (certain progenitor cells are implicated in cancer origin, subtypes, and progression)Degenerative disease (such as neurodegeneration where progenitor cells may be involved in repair)Regenerative medicine (tissue engineering, cell-based therapy)Other (various, depending on tissue or organ context)
05

Safety considerations

Risks relate to context—e.g., in transplantation or therapies involving progenitor cells: tumorigenicity, immune rejection, off-target differentiation; in cancer, progenitor cell expansion may underlie progression or resistance
06

Biomarkers

No universal biomarkers; markers are specific to the progenitor cell subtype and tissue (e.g., CD34 for hematopoietic progenitors, various others for neural, epithelial, or endothelial subtypes)

Beyond the preview

Go deeper on Progenitor cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progenitor cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call